PrimeRFP SCOUT · Federal Contract Recompete Brief

HT942524D0011Development of NOVEL DRUG particles for — Crititech Particle Engineering Solutions, LLC

Crititech Particle Engineering Solutions, LLC holds $318K across 4 federal awards, concentrated at Department of Defense (DOD). This PIID sits alongside 1 related award in the incumbent pipeline. Set-aside status: Unrestricted.

Defense Health Agency
Awarding office
Crititech Particle Engineering Solutions, LLC
Recipient
—
Estimated value
AJ11
PSC
Unrestricted
Set-aside

Watch this recompete

One email. No account. We ping you if the window moves.

Contract facts

Unrestricted
Contract numberHT942524D0011
Also listed asHT9425-24-D-0011
AgencyDefense Health Agency
Awarding officeDefense Health Agency
Awarding agencyDepartment of Defense (DOD)
Funding agencyDepartment of Defense (DOD)
IncumbentCrititech Particle Engineering Solutions, LLC
UEIQMLLX81RZ6V9
PSCAJ11
Related solicitationHT942524R0116

DEVELOPMENT OF NOVEL DRUG PARTICLES FOR INHALATIONAL THERAPY is a federal Unrestricted award for Defense Health Agency held by Crititech Particle Engineering Solutions, LLC. Estimated value —. Related solicitation HT942524R0116.

DEVELOPMENT OF NOVEL DRUG PARTICLES FOR INHALATIONAL THERAPY

Bonuses end Sept 30

Want the durability read on HT942524D0011? One Pursuit Analysis, $500, inside 48 business hours.

  • 48 business hours
  • $500
  • Credits toward the Pack
Buy one Pursuit Analysis — $500

Incumbent footprint

Public record

Crititech Particle Engineering Solutions, LLC — $318K obligated across 4 awards (firm-wide, all agencies).

Sole agency: Department of Defense (DOD)
Department of Defense (DOD)$318K · 100% of firm total
Open full company profile →

Related awards

Same incumbent
HT942526FE005
DEVELOPMENT OF NOVEL DRUG PARTICLES FOR INHALATIONAL THERAPY
$141K
Dec 2, 2026

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract HT942524D0011?

HT942524D0011 (Development of NOVEL DRUG particles for) is a Defense Health Agency award with an estimated value of —, currently held by Crititech Particle Engineering Solutions, LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is HT9425-24-D-0011?

HT9425-24-D-0011 is the dashed form of PIID HT942524D0011 (Development of NOVEL DRUG particles for), held by Crititech Particle Engineering Solutions, LLC. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded HT942524D0011?

Defense Health Agency awarded HT942524D0011 to Crititech Particle Engineering Solutions, LLC.

Who is the incumbent on HT942524D0011?

Crititech Particle Engineering Solutions, LLC is the incumbent with $318K across 4 related awards in SCOUT’s public footprint.

When does Crititech Particle Engineering Solutions, LLC’s HT942524D0011 come up for recompete?

SCOUT tracks a period-of-performance end of an unstated date. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Want the durability read on HT942524D0011? One Pursuit Analysis, $500, inside 48 business hours.

One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.

Get the free Exposure Check

No card · under a minute · then the Sprint menu

Buy one Pursuit Analysis — $500

Credits toward the Sprint Pack

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthly
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/HT942524D0011